Records containing: Hepatitis C
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2010-02-22PREDICT - Prospective Observational Study Of A Cohort Of Naïve Patients With Chronic Hepatitis C Infected With Hepatitis C Virus Genotype 1 Low Viral Load (HCV LVL G1) And Treated With Peg-Intron 1.5 ug/Kg/Week Plus Rebetol 800-1200 mg/Day Who Achieved A Negative HCV-RNA At Week 4 and at Week 24
-
CLINICAL_TRIALS study record update · 2010-02-19Prophylactic Treatment of Peginterferon-associated Psychopathology. A Double-blind Placebo-controlled Trial on the Effects of Escitalopram (Lexapro®) in Patients Treated With Peginterferon and Ribavirin (POPS Study)
-
CLINICAL_TRIALS study record update · 2010-01-13Treatment of Cholestatic Pruritus With Sertraline
-
CLINICAL_TRIALS study record update · 2010-01-08Use of Mucomyst (NAC) to Ameliorate Oxidant Stress as Measured by Surrogate Serum in Patients With Hepatitis C
-
CLINICAL_TRIALS study record update · 2010-01-07A Phase 1, Randomized, Double-blind, Placebo-controlled, Sequential-group, Multiple-dose, Drug-drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2009-09-23Blood Antioxidant Status in Chronic Hepatitis C Patients Before and After Antioxidant Supplementation: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2009-09-18A Placebo-controlled, Double-blind, Randomized, Single Dose, Dose Escalating Trial in Healthy Men to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPC3649
-
CLINICAL_TRIALS study record update · 2009-09-17A Study on PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin) in Iranian Hemophilic Patients With Chronic Hepatitis C Infection
-
CLINICAL_TRIALS study record update · 2009-09-16A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of MK7009 in Hepatitis C Infected Patients
-
CLINICAL_TRIALS study record update · 2009-08-19Evaluation of Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron / Rebetol in Conjunction With a Patient Assistance Program - Non Interventional Observational Study.
-
CLINICAL_TRIALS study record update · 2009-08-13Alcohol Use Reduction in Methadone Individuals With HCV
-
CLINICAL_TRIALS study record update · 2009-08-07Pharmacological Interactions Between Zidovudine and Ribavirin in HCV-HIV Co-Infected Patients Treated With Rebetron or Peg-Intron Plus Ribavirin
-
CLINICAL_TRIALS study record update · 2009-06-02Evaluation of Adherence Rate in Patients Receiving PegIntron Pen / Rebetol for Hepatitis C
-
CLINICAL_TRIALS study record update · 2009-06-02Evaluation of Satisfaction in Patients Receiving PegIntron Pen / Rebetol for Hepatitis C
-
CLINICAL_TRIALS study record update · 2009-03-06Usefulness of Adding Thalidomide to Peginterferon and Ribavirin in Patients With Hepatitis C and Resistance to Interferon. Phase II
-
CLINICAL_TRIALS study record update · 2009-02-16Request for Blood Samples to Examine the Effect of Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Patients With Hepatitis C and in Patients Coinfected With Hepatitis C and HIV
-
CLINICAL_TRIALS study record update · 2009-02-11The Effects of Preventive Versus on Demand Nutritional Advice and Support on the Nutritional Status of Patients During Antiviral Therapy for Hepatitis C A Randomized, Multi Center Trial
-
CLINICAL_TRIALS study record update · 2009-02-06A Pilot, Open Label, Multicenter, Randomized Clinical Trial on Lopinavir/Ritonavir-Monotherapy vs Lopinavir/Ritonavir Plus Selected Nucs, in HIV/HCV Coinfected Patients With Chronic Hepatitis C or Compensated Cirrhosis, Starting Treatment With Ribavirin and Pegylated Interferon
-
CLINICAL_TRIALS study record update · 2009-02-06Pilot, Multicenter, Randomized Study on Lopinavir/Ritonavir-Monotherapy vs Lopinavir/Ritonavir Plus Selected Nucs, in HIV/HCV ARV-Naive Coinfected Patients With Chronic Hepatitis C or Compensated Cirrhosis, Starting Treatment With Ribavirin and Pegylated Interferon
-
CLINICAL_TRIALS study record update · 2009-01-21VISN 20 Prophylactic Treatment of IFN-Induced Depression in Hepatitis C
-
CLINICAL_TRIALS study record update · 2009-01-21Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2008-12-09Cooperative Agreement to Develop, Implement, and Evaluate Viral Hepatitis and Training
-
CLINICAL_TRIALS study record update · 2008-12-09Cooperative Agreement to Develop, Implement, and Evaluate Viral Hepatitis and Training
-
CLINICAL_TRIALS study record update · 2008-09-09Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C
-
CLINICAL_TRIALS study record update · 2008-08-01Dynamics of Hepatitis C Infection in Subjects With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Receiving Highly Active Antiretroviral Therapy (HAART)